Skip to main content
. 2022 Aug 15;2(8):806–813. doi: 10.1158/2767-9764.CRC-21-0143

FIGURE 4.

FIGURE 4

Immune-related adverse events (irAE) within the entire treatment cohort. A, Overall irAE rate as a function of race/ethnic group. B, ORR as a function of irAE for the ICI monotherapy cohort. PR, partial response; SD, stable disease; PD, progressive disease.